Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver,...
Ottawa, Ontario--(Newsfile Corp. - December 16, 2024) - The Canadian Counselling and Psychotherapy Association (CCPA) has long recognized the critical...
HUNTSVILLE, Ala., Dec. 16, 2024 /PRNewswire/ -- iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder...
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the...
Brian Scherner shares his perspective on community health in new online feature. PORTLAND, OR / ACCESSWIRE / December 16, 2024...
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global online therapy services market size is estimated to grow by USD 16.16 billion...
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a survey on nicotine use...
Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -...
Health Union earns Gold for "Patient Insider," its innovative patient influencer experience, as well as recognition for outstanding achievements in...
The nation's leading virtual psychiatry and therapy provider reflects on 25 years of innovation, advancing integrated care and improving mental...
Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for...
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
New collaboration delivers confidential and convenient telehealth services to address erectile dysfunction for men DALLAS, Dec. 11, 2024 /PRNewswire/ --...
CHICAGO, Dec. 11, 2024 /PRNewswire/ -- Aon plc (NYSE: AON) reports that more U.S. hospitals are reporting steady or lower employee...
DALLAS, Dec. 11, 2024 /PRNewswire/ -- Every Black Life Matters (EBLM) supports the jury's not guilty verdict for Daniel Penny,...
Data Shows Pomelo's Virtual Care Model Reduces Total Cost of Maternal Care in Medicaid Population, Lowers NICU and ER Utilization for...
LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for...
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is...
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose...
MORRISTOWN, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment...